Survival and years of life lost in different age cohorts of patients with multiple myeloma. Ludwig H, Bolejack V, Crowley J, Bladé J, Miguel JS, Kyle RA, Rajkumar SV, Shimizu K, Turesson I, Westin J, Sonneveld P, Cavo M, Boccadoro M, Palumbo A, Tosi P, Harousseau JL, Attal M, Barlogie B, Stewart AK, Durie B.
J Clin Oncol. 2010 Mar 20 ;28(9):1599-605.
Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation : a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring. Gaziev J, Nguyen L, Puozzo C, Mozzi AF, Casella M, Donnorso MP, Gravina P, Sodani P, Marziali M, Isgrò A, Simone MD, Andreani M, Formosa A, Testi M, Federici G, Bernardini S, Lucarelli G.
Blood. 2010 Mar 17. [Epub ahead of print]PMID : 20237319
Conditional TPM3-ALK and NPM-ALK transgenic micedevelop reversible ALK-positive early B cell lymphoma/leukemia. Giuriato S, Foisseau M, Dejean E, Felsher DW, Al Saati T, Demur C, Ragab A, Kruczynski A, Schiff C, Delsol G, Meggetto F.
Blood. 2010 Mar 11. [Epub ahead of print]PMID : 20223922
Vgamma9Vdelta2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. D’Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, Guggino G, Meraviglia S, Caccamo N, Messina A, Salerno A, Di Raimondo F, Vigneri P, Stassi G, Fourniè JJ, Dieli F.
J Immunol. 2010 Mar 15 ;184(6):3260-8.
MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.
Clin Chem. 2010 Apr ;56(4):603-12.
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.Mesía R, Rivera F, Kawecki A, Rottey S, Hitt R, Kienzer H, Cupissol D, De Raucourt D, Benasso M, Koralewski P, Delord JP, Bokemeyer C, Curran D, Gross A, Vermorken JB.
Ann Oncol. 2010 Mar 24. [Epub ahead of print]PMID : 20335368
NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids. Ferguson JF, Phillips CM, McMonagle J, Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C, Gjelstad IM, Drevon CA, Blaak EE, Saris WH, Leszczyńska-Gołąbek I, Kiec-Wilk B, Risérus U, Karlström B, Lopez-Miranda J, Roche HM.
Atherosclerosis. 2010 Mar 27. [Epub ahead of print]PMID : 20409549
Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study.Hartwich J, Leszczynska-Golabek I, Kiec-Wilk B, Siedlecka D, Pérez-Martinez P, Marin C, López-Miranda J, Tierney A, Monagle JM, Roche HM, Defoort C, Wolkow P, Dembinska-Kiec A.
Scand J Clin Lab Invest. 2010 Apr 19 ;70(3):201-8.
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study. Gulseth HL, Gjelstad IM, Tierney AC, Shaw DI, Helal O, Hees AM, Delgado-Lista J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI, Drevon CA.
Br J Nutr. 2010 Mar 5:1-4.
Participants’ uptake of clinical trial results : a randomised experiment.Mancini J, Genre D, Dalenc F, Ferrero JM, Kerbrat P, Martin AL, Roché H, Maylevin F, Tarpin C, Viens P, Genève J, Julian-Reynier C.
Br J Cancer. 2010 Mar 30 ;102(7):1081-4.
Additive effect of polymorphisms in the IL-6, LTA, and TNF-alpha genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components.Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, Mehegan J, Peloso GM, Cupples LA, Shen J, Ordovas JM, McManus R, Hercberg S, Portugal H, Lairon D, Planells R, Roche HM.
J Clin Endocrinol Metab. 2010 Mar ;95(3):1386-94.
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome.Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Ris U, Roche HM, Drevon CA, Birkeland KI.
Diabetes Care. 2010 Apr ;33(4):923-5.
Gene-nutrient interactions in the metabolic syndrome : single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, Helal O, Lairon D, Planells R, Shaw DI, Lovegrove JA, Gjelstad IM, Drevon CA, Blaak EE, Saris WH, Leszczynska-Golabek I, Kiec-Wilk B, Risérus U, Karlström B, Miranda JL, Roche HM.
Am J Clin Nutr. 2010 Mar ;91(3):794-801.
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone.Avet-Loiseau H, Soulier J, Fermand JP, Yakoub-Agha I, Attal M, Hulin C, Garderet L, Belhadj K, Dorvaux V, Minvielle S, Moreau P ; IFM and MAG groups.
Leukemia. 2010 Mar ;24(3):623-8.